Answers from the Lab cover art

All Episodes

Answers from the Lab — 389 episodes

#
Title
1

Unlock the Full Potential of Research Data

2

A New Mindset for Leading Through Change

3

Key Components of Innovation Success

4

Better Testing for Bleeding Disorders

5

Lab Outreach Delivers Value, Growth, and Strategic Advantage

6

Personalized Therapy Growth Driven by Clinical Diagnostics

7

How Pharmacogenomics Deliver More Precise Cancer Therapy

8

Risks Increase as Ticks, Mosquitoes, and Similar Vectors Spread

9

Lab Stewardship in Modern Healthcare

10

Unique Assays Advance Care of Complex Autoimmune Skin Conditions

11

Digital Advances: What’s Next for Clinical Diagnostics?

12

Preeclampsia Test Helps Extend Pregnancy to Improve Outcomes

13

Breakthrough Test Enhances Peripheral Neuropathy Care and Research

14

How Strategic Collaborations Transform Clinical Diagnostics

15

Innovation and Resilience in Lab Logistics

16

2026 Forecast: Trends Shaping the Future of Diagnostics

17

Speed Without Sacrifice: How Diagnostics Can Move Quickly and Safely

18

Breakthroughs and Trends That Defined Lab Medicine in 2025

19

Accelerating Research and Development With BioPharma Diagnostics

20

Unlocking the Unknown With Metagenomics

21

Forging Collaborations That Deliver Better Outcomes

22

Advancing Precision Medicine Through Therapeutic Tests

23

Developments for LDT Regulation and Laboratory Reimbursement: Bill Morice, M.D., Ph.D.

24

Self-Collection Testing Expands to New Areas: Elitza Theel, Ph.D.

25

Flesh-Eating Organisms Making the News: Bill Morice, M.D., Ph.D.

26

Whole Exome Sequencing Reflex Test Offers Cost-Effective Diagnosis: Cherisse Marcou, Ph.D., and Kristen Rasmussen, M.S., CGC

27

Rabbits, Chikungunya, and More Viral News: Matthew Binnicker, Ph.D.

28

The Promise, Challenges, and Global Impact of AI Tools: Bill Morice, M.D., Ph.D.

29

New Tools for the Changing Landscape of Tick-Borne Diseases: Elitza Theel, Ph.D.

30

How Investment Trends May Impact Clinical Diagnostics: Bill Morice, M.D., Ph.D.

31

Expanded assay better identifies hereditary pancreatitis: Linda Hasadsri, M.D., Ph.D., and Huong Cabral, M.S., CGC

32

How the Evolving Role of Diagnostics and Platforms Impact Healthcare: Bill Morice, M.D., Ph.D.

33

Labile Copper Test Enhances Evaluation for Wilson's Disease: Joshua Bornhorst, Ph.D.

34

Assay Aids Diagnosis of Resistant Hypertension: John Lieske, M.D., and Sandra Taler, M.D.

35

Advancing Neuropathy Diagnosis With Laboratory Testing and Algorithms: Div Dubey, M.B.B.S

36

Quantitative Adenovirus Assay Better Informs Post-Transplant Care: Joseph Yao, M.D.

37

Global Diagnostic Trends and What They Mean for Laboratories: Bill Morice, M.D., Ph.D.

38

Five Ways Laboratories Maximize Health System Success: Bill Morice, M.D., Ph.D.

39

Laboratory Medicine Central to Tick-Borne Disease Response: Bill Morice, M.D., Ph.D.

40

Revolutionary Technology Advances Diagnosis of Neurodegenerative Disorders: Bill Morice, M.D., Ph.D.

41

Reflex Test Guides Precise Care for Arsenic Exposure: Paul Jannetto, Ph.D.

42

What Happens Next? Lab-Developed Test Rule Vacated: Bill Morice, M.D., Ph.D.

43

Comprehensive Genetic Test Guides Prescribing of a Transplant Anti-Rejection Drug: Jessica Wright, Pharm.D., BCACP

44

Liquid Biopsy Enables Precision Cancer Care: Bill Morice, M.D., Ph.D.

45

The Emergence of Retail Health: Bill Morice, M.D., Ph.D.

46

Significant Infectious Disease Activity Continues: Bill Morice, M.D., Ph.D.

47

The Impacts of STI Testing Innovation: Elitza Theel, Ph.D.

48

Why a Quality Management Program is Essential: Bill Morice, M.D., Ph.D.

49

Importance of Monitoring Business Trends in Diagnostics: Bill Morice, M.D., Ph.D.

50

Assay identifies most known membranous nephropathy antigens: Sanjeev Sethi, M.D., Ph.D.

51

Innovations Set to Shape the Industry in 2025: Bill Morice, M.D., Ph.D.

52

Benefits of Automation in the Laboratory: Erin Graf, Ph.D.

53

The Latest on H5 Avian Influenza: Bill Morice, M.D., Ph.D.

54

The Rapid Evolution of Artificial Intelligence: Bill Morice, M.D., Ph.D.

55

Global Vigilance in Preventing Infectious Disease Outbreaks: Bill Morice, M.D., Ph.D.

56

Expanding Lab Access to Improve Health Equity: Bill Morice, M.D., Ph.D.

57

Making Informed Decisions About Genetic Testing: Carrie Lahner, M.S., CGC, and April Studinski Jones, M.S., CGC

58

Genetic Tests Identify Risk of Irinotecan-Induced Toxicity: John Logan Black, M.D.

59

What’s Causing Outbreaks of Preventable Infectious Diseases: Bill Morice, M.D., Ph.D.

60

Preparing for Respiratory Viruses: Bill Morice, M.D., Ph.D.

61

Hypermethylation Test Guides Lynch Syndrome Care: Megan Hoenig, M.S., M.P.H., CGC

62

Navigating Technology Disruptions: John Osborn

63

Plasma Test Increases Access to Alzheimer’s Testing: Alicia Algeciras-Schimnich, Ph.D.

64

The Science of Diagnosing Rare Platelet Disorders: Dong Chen, M.D., Ph.D.

65

Overcoming Health Threats Through Public-Private Lab Partnerships: Bill Morice, M.D., Ph.D.

66

Unique Test Screens for Recently Identified Peripheral Neuropathy: Matthew Schultz, Ph.D., and Amy White, M.S., CGC

67

Advancing Lupus Treatment With Modern Diagnostics: Bill Morice, M.D., Ph.D.

68

Panel Detects Demyelinating Neuropathy Biomarkers: John Mills, Ph.D., and Divyanshu Dubey, M.B.B.S.

69

Novel Laboratory Tests Transform Lupus Management: Bill Morice, M.D., Ph.D.

70

Genetic Tests Identify Risk of Fluoropyrimidine-Induced Toxicity: Ann Moyer, M.D., Ph.D.

71

Breakthrough Lab Tests for Detecting Alzheimer’s Disease: Bill Morice, M.D., Ph.D.

72

Trends in the Laboratory and Diagnostic Testing Market: Bill Morice, M.D., Ph.D.

73

Why Mpox is a Public Health Emergency: Matthew Binnicker, Ph.D.

74

Tracking the Latest Pathogens: Bill Morice, M.D., Ph.D.

75

Panel Boosts Therapeutic Monitoring of IBD Drug: Maria Alice Willrich, Ph.D., and Melissa Snyder, Ph.D.

76

Global Industry Activities: Bill Morice, M.D., Ph.D.

77

Alarming Increase in Dengue Cases: Elitza Theel, Ph.D.

78

Scaling Knowledge With AI: Bill Morice, M.D., Ph.D.

79

An Impactful Supreme Court Decision: Bill Morice, M.D., Ph.D.

80

The Metals Laboratory Tests Beethoven’s Hair: Paul Jannetto, Ph.D.

81

COVID-19 and Avian Flu: Bill Morice, M.D., Ph.D.

82

The Platform Transformation of Healthcare: Bill Morice, M.D., Ph.D.

83

Updates Streamline Autoimmune Neurology Testing: Anastasia Zekeridou, M.D., Ph.D.

84

Infectious Diseases on the Move: Bill Morice, M.D., Ph.D.

85

Tests Aid Diagnosis of Cancer-Associated Neurological Disorders: Divyanshu Dubey, M.B.B.S.

86

Get to Know DLMP’s Vice Chair of Research: Peter Lucas, M.D., Ph.D.

87

Avian Flu Outbreaks and New COVID-19 Variants: Matthew Binnicker, Ph.D.

88

Enhanced Solid Tumor NGS Panel Broadens Genetic-Variants Detection: Robert Jenkins, M.D., Ph.D., Stephanie Smoley, CG(ASCP), and Beth Pitel, M.S.

89

New Panels Help Find Cause of Rapidly Progressive Dementia: Gregory (Gregg) Day, M.D.

90

Get to Know the DLMP Chair: Eric Hsi, M.D.

91

Oral fluid offers an alternative specimen for controlled substance monitoring: Paul Jannetto, Ph.D.

92

FDA Issues Final Rule to Regulate LDTs: Bill Morice, M.D., Ph.D.

93

The Growing Crisis of Antimicrobial Resistance: Robin Patel, M.D.

94

Assay provides quick diagnosis of VEXAS syndrome: David S. Viswanatha, M.D.

95

Alzheimer’s Disease and Testing Innovations: Bill Morice, M.D., Ph.D.

96

Assay identifies patients eligible for new ovarian cancer drug: Maryam Shahi, M.D

97

Lab Week and Noteworthy News: Bill Morice, M.D., Ph.D.

98

Assay monitors response to monoclonal antibody therapy: Maria Alice Willrich, Ph.D.

99

Tick Season Outlook: Elitza Theel, Ph.D.

100

Noninvasive plasma biomarker testing provides faster answers: Alicia Algeciras-Schimnich, Ph.D.

101

Dengue Outbreaks and Advancements in Colon Cancer Screening: Bill Morice, M.D., Ph.D.

102

Assay identifies rare tick-borne bacteria: Bobbi Pritt, M.D.

103

Why Measles Is on the Rise: Matthew Binnicker, Ph.D.

104

Targeted panel boosts accuracy of hereditary pancreatitis testing: Experts: Linda Hasadsri, M.D., Ph.D., and Huong T. Cabral, M.S., C.G.C.

105

Industry Updates From the Nation’s Capital: Bill Morice, M.D., Ph.D.

106

Test identifies Lynch syndrome for targeted cancer monitoring: Wei Shen, Ph.D., and Rhianna Urban, M.S., CGC

107

Syphilis Testing Updates: Elitza Theel, Ph.D.

108

Testing aids nicotine-use cessation: Paul Jannetto, Ph.D.

109

Final Rule on LDTs May Be Coming Soon: Bill Morice, M.D., Ph.D.

110

Black History Month: Bill Morice, M.D., Ph.D.

111

Adrenal Gland Tumors: Stefan Grebe, M.D., Ph.D., and Irina Bancos, M.D.

112

Test panel guides diagnosis of early onset IBD: Ann Moyer, M.D., Ph.D.

113

Emerging and Reemerging Diseases: Bill Morice, M.D., Ph.D.

114

Tests aid diagnosis of primary biliary cholangitis: Anne Tebo, Ph.D.

115

Assay enhances and simplifies M-proteins screening: David Murray, M.D., Ph.D.

116

The Pulse on Global Diagnostics: Bill Morice, M.D., Ph.D.

117

Assay stratifies pregnant women's preeclampsia risk: Joshua Bornhorst, Ph.D.

118

Evolution of Syphilis: Elitza Theel, Ph.D.

119

A New Year with Familiar Viruses: Bill Morice, M.D., Ph.D.

120

Lipid assay improves cardiovascular risk prediction: Jeff Meeusen, Ph.D.

121

Test helps identify elusive central nervous system pathogens: Robin Patel, M.D.

122

Unique testing helps identify cause of sudden cardiac death: Linnea Baudhuin, Ph.D., and Kate Kotzer, M.S., CGC

123

Assay finds genetic cause of low bile flow: Devin Oglesbee, Ph.D.

124

The Past, Present, and Future of Diagnostics: Bill Morice, M.D., Ph.D.

125

Assay identifies biomarker of autoimmune encephalitis subtype: Andrew McKeon, M.B., B.Ch., M.D.

126

Milestone Treatments for Sickle Cell Disease: Bill Morice, M.D., Ph.D.

127

Panel offers proactive drug monitoring for IBD: Maria Willrich, Ph.D., and Melissa Snyder, Ph.D.

128

Comments on the FDA’s Proposed Rule: Bill Morice, M.D., Ph.D.

129

Protecting Against Winter Respiratory Viruses: Bill Morice, M.D., Ph.D.

130

Congressional and Federal Updates: Bill Morice, M.D., Ph.D.

131

Perspectives from Washington, D.C.: Bill Morice, M.D., Ph.D.

132

RNA test identifies large B-cell lymphoma subtypes: Lisa Rimsza, M.D.

133

Safeguards for AI in Healthcare: Bill Morice, M.D., Ph.D.

134

A Possible Cure for Sickle Cell Disease: Bill Morice, M.D., Ph.D.

135

Opportunities Around At-Home Testing: Bill Morice, M.D., Ph.D.

136

How AI Can Add Value to Laboratory Medicine: Bill Morice, M.D., Ph.D.

137

Transformative Technologies: Bill Morice, M.D., Ph.D.

138

Proposed Regulations for Laboratory Developed Tests: Bill Morice, M.D., Ph.D.

139

Seasonal Outlook of Respiratory Viruses: Matthew Binnicker, Ph.D.

140

Circulating Strains of COVID-19: Bill Morice, M.D., Ph.D.

141

What to Know About Leprosy: Nancy Wengenack, Ph.D.

142

Flea-borne Typhus: Elitza Theel, Ph.D.

143

Opioid Addiction and Substance Abuse Testing: Paul Jannetto, Ph.D.

144

Summertime Pathogens: Bill Morice, M.D., Ph.D.

145

Modern-day Outbreaks: Bill Morice, M.D., Ph.D.

146

Test for LDL subtype helps manage coronary risk: Vlad Vasile, M.D., Ph.D., and Leslie Donato, Ph.D.

147

Learning Through Teaching Global Health: Bill Morice, M.D., Ph.D.

148

Panel pinpoints causes of genetic hearing loss: Nicole Boczek, Ph.D., and Melanie Meyer, M.S, CGC

149

Pioneering Research in Autoimmune Neurology: Vanda Lennon, M.D., Ph.D.

150

Breast cancer panel halves turnaround time: Wei Shen, Ph.D.

151

Dengue and Chikungunya Outbreaks: Elitza Theel, Ph.D.

152

Gynecological NGS panels offer cost-effective cancer testing: Sounak Gupta, M.B.B.S., Ph.D.

153

Malaria in the United States: Bill Morice, M.D., Ph.D.

154

Urologic panels provide focused cancer testing: Sounak Gupta, M.B.B.S., Ph.D.

155

The Latest on Measles: Matthew Binnicker, Ph.D.

156

Results report simplifies urine test interpretation: John Lieske, M.D.

157

FDA Oversight of Lab-Developed Tests: Bill Morice, M.D., Ph.D.

158

Multigene panel provides efficient ataxia diagnosis: Angela Pickart, M.S., CGC, and Emily Lauer, M.S., CGC

159

Remote Diagnostics: Bill Morice, M.D., Ph.D.

160

Updated assay guides diagnosis of autoimmune liver disease: Anne Tebo, Ph.D.

161

Diagnosing Lyme Disease: Bill Morice, M.D., Ph.D.

162

BioPharma Diagnostics: Bill Morice, M.D., Ph.D.

163

The impact of AI: Bill Morice, M.D., Ph.D.

164

West Nile virus: Elitza Theel, Ph.D.

165

The progression of the diagnostic landscape: Bill Morice, M.D., Ph.D.

166

Endemic fungal infections in North America: Elitza Theel, Ph.D.

167

A strong community of lab professionals: Bill Morice, M.D., Ph.D., and Susan Van Meter

168

Test detects autoimmune neurology disorders linked to cancer: Sean Pittock, M.D.

169

Emerging fungal pathogens: Dr. Nancy Wengenack

170

Leading important industry conversations: Bill Morice, M.D., Ph.D.

171

IDH assay facilitates timelier leukemia treatment: Rong He, M.D.

172

Neurofilament light chain: Bjorn Oskarsson, M.D.

173

Approaching tick season: Bill Morice, M.D., Ph.D.

174

An efficient, cost-effective, fungal testing alternative: Elitza Theel, Ph.D.

175

Avian influenza and reflecting on three years of COVID-19: Matthew Binnicker, Ph.D.

176

Test assesses all inherited Parkinson's disease genes: Zhiyv (Neal) Niu, Ph.D., and Rodolfo Savica, M.D., Ph.D.

177

Neuromuscular gene panel provides comprehensive analysis: Zhiyv (Neal) Niu, Ph.D., and Christopher Klein, M.D.

178

Amplifying the voice of the lab during policymaking: Dr. Bill Morice

179

Whole genome sequencing streamlines diagnosis: Nicole Boczek, Ph.D., and Sarah Barnett, M.S., CGC

180

Rising rates of group A streptococcus and antibiotic resistant gonorrhea: Dr. Robin Patel

181

Chromosomal microarray better informs brain tumor diagnosis: Robert Jenkins, M.D., Ph.D.

182

When to test for norovirus: Dr. Bill Morice

183

THCU: Paul Jannetto, Ph.D., and Loralie Langman, Ph.D.

184

Sharing Mayo Clinic knowledge globally while learning from other cultures: Dr. Bill Morice

185

Novel biomarkers added to movement disorders profile: Andrew McKeon, M.B., B.Ch., M.D.

186

How digital pathology is changing patient care at Mayo Clinic: Dr. Joaquin Garcia

187

New gene panel enhances brain tumor profiles: Cristiane (Cris) Ida, M.D.

188

Triple-demic update and the future of at-home testing: Dr. Bill Morice

189

Recap of this year’s J.P. Morgan Healthcare Conference and COVID-19 update: Dr. Bill Morice

190

Novel panel identifies toxins linked to asthma and GI diseases: Melissa Snyder, Ph.D.

191

Legislative update and at-home testing: Dr. Bill Morice

192

Why cancer death rates are declining: Dr. Ansell

193

Respiratory virus update and a new measles test: Dr. Matthew Binnicker

194

Predictions for 2023: Dr. Bill Morice

195

The laboratory’s role in spurring innovation: Dr. Bill Morice

196

Respiratory illness updates and health care economics: Dr. Bill Morice

197

Ensuring quality in the lab: Dr. Bill Morice

198

Liquid biopsy offers noninvasive DNA testing for cancer care: Gang Zheng, M.D., Ph.D., and Aaron Mansfield, M.D.

199

Staying safe during the holidays: Dr. Bill Morice

200

Carrier Screening: Linda Hasadsri, M.D., Ph.D.

201

The challenges facing most health care leaders: Dr. Bill Morice

202

Novel malabsorption panel speeds diagnosis: Puanani Hopson, D.O.

203

Legislation, leadership, and MayoComplete: Dr. Bill Morice

204

Comprehensive panel boosts GIST diagnosis sensitivity: Rondell Graham, M.B.B.S.

205

Testing is essential in the months ahead: Dr. Bill Morice

206

Melanoma panel provides more tumor information: Ruifeng (Ray) Guo, M.D., Ph.D.

207

Colorectal panel provides detailed cancer information: Rondell Graham, M.B.B.S.

208

Focused lung panel informs the use of targeted cancer therapies: Ying-Chun Lo, M.D., Ph.D.

209

Unique pediatric evaluation targets relevant autoimmune/CNS antibodies: Andrew McKeon, M.B., B.Ch., M.D.

210

Preparing for respiratory infection season: Dr. Matthew Binnicker

211

Chain of Custody Testing: Loralie Langman, Ph.D.

212

Shifting from pandemic to endemic: Dr. Bill Morice

213

Virus outlook heading into fall: Dr. Bill Morice

214

Advocating for lab legislation: Dr. Bill Morice

215

PIK3CA assay guides treatment of progressing breast cancer: Katherine Geiersbach, M.D.

216

Leading diagnostics into the future: Dr. Bill Morice

217

PCD test provides definitive diagnosis of a rare disease: Joseph Maleszewski, M.D., and Marie-Christine Aubry, M.D.

218

PETH: Paul Jannetto, Ph.D.

219

Looking at the big picture: Dr. Bill Morice

220

Precision therapeutics can individualize depression treatment: Ann Moyer, M.D., Ph.D., and Paul Jannetto, Ph.D.

221

State-of-the-art genetics panel optimizes kidney disease treatment: Linnea M. Baudhuin, Ph.D., and Emily K. Thoreson, M.S., CGC

222

Monkeypox and legislation updates: Dr. Bill Morice

223

CIDP: Divyanshu (Div) Dubey, M.B.B.S.

224

Ongoing evolution of monkeypox: Dr. Bill Morice

225

PMND1: John Lieske, M.D.

226

Monkeypox testing progress: Dr. Bill Morice

227

Enhanced detection of genetic mutation to optimize leukemia treatment: Rong He, M.D.

228

Operationalizing monkeypox testing: John Osborn

229

Nonradioactive assay helps diagnose heparin reaction: Rajiv Pruthi, M.B.B.S.

230

Monkeypox declared a global public health emergency: Dr. Bill Morice

231

FDA-approved test expands options for Alzheimer's disease: Joshua Bornhorst, Ph.D.

232

Managing the current rise in COVID cases: Dr. Bill Morice

233

Scaling monkeypox testing and the new COVID variant: Dr. Bill Morice

234

New SALSA bill and monkeypox testing at Mayo: Dr. Bill Morice

235

The Latest on Monkeypox and Lab Legislation: Dr. Bill Morice

236

The age of pandemics: Dr. Bill Morice

237

WESDX: Cherisse Marcou, Ph.D., and Marissa Ellingson, M.S., CGC

238

Monkeypox: Dr. Bill Morice

239

Being Mindful of Mental Health: John Black, M.D.

240

Viruses and variants: Dr. Bill Morice

241

Recent Outbreaks of Viral Infections: Dr. Matt Binnicker

242

VALID Act: Dr. Bill Morice

243

Tick-borne Disease Testing: Elitza Theel, Ph.D.

244

Lab Legislation Update: Dr. Bill Morice

245

NFLC: Alicia Algeciras, Ph.D.

246

Lab Medicine’s Role in the Clinical Practice: Dr. Bill Morice

247

ADMPU: Loralie Langman, Ph.D., and Paul Jannetto, Ph.D.

248

Regulation of Lab Developed Tests: Dr. Bill Morice

249

Advancements in autoimmune neurology: Dr. Andrew McKeon

250

COVID-19 Update: Dr. Bill Morice

251

IBDP2: Melissa Snyder, Ph.D.

252

CLIA-Licensed Laboratories: Dr. Bill Morice

253

Chromium and Cobalt: Paul Jannetto, Ph.D.

254

Laboratory Innovation: Dr. Bill Morice

255

TPNUQ: Ann Moyer, M.D., Ph.D.

256

Lab developed tests: Dr. Bill Morice

257

MSP3: Maria Alice Willrich, Ph.D.

258

New COVID-19 variants: Dr. Bill Morice

259

Oversight of the laboratory industry: Dr. Bill Morice

260

Urinary ammonium testing: John Lieske, M.D.

261

New Strategies to Combat COVID-19: Dr. Bill Morice

262

New Masking Guidelines: Dr. Bill Morice

263

Extended spectrum beta lactamase testing: Audrey Schuetz, M.D.

264

Informatics and Laboratory Medicine: Dr. David McClintock

265

Stiff-Person/PERM Evaluation: Andrew McKeon, M.B., B.Ch., M.D.

266

Adapting as COVID-19 Changes: Dr. Bill Morice

267

Interpreting Lab Test Results: Dr. Bill Morice

268

Tackling COVID-19 Misinformation: Dr. Bill Morice

269

A Global Perspective on COVID-19: Dr. Bill Morice

270

COVID-19 Antigen Tests: Dr. Bill Morice

271

SARS-CoV-2, Influenza A and B, and Respiratory Syncytial Virus (RSV) testing: Joseph Yao, M.D.

272

Respiratory Virus Testing: Dr. Matthew Binnicker

273

Omicron Update: Dr. Bill Morice

274

Reflections on how far we’ve come: Dr. Bill Morice

275

Autoimmune Axonal Testing: Divyanshu (Div) Dubey, M.B.B.S.

276

At-Home COVID-19 Tests: Dr. Brad Karon

277

Holiday Safety and COVID-19: Dr. Bill Morice

278

The State of COVID-19 Now: Dr. Bill Morice

279

Omicron Variant: Dr. Bill Morice

280

CYPZ: Michelle Kluge, M.S., CGC

281

Lab-Developed Tests: Shannon Bennett

282

Hereditary Oncology Testing: Wei Shen, Ph.D.

283

COVID-19 Antibody Testing: Dr. Elitza Theel

284

IDENT: Audrey Schuetz, M.D.

285

COVID-19, Moving Forward: Dr. Bill Morice

286

The State of COVID-19 Today: Dr. Bill Morice

287

The Global Impact of COVID-19: Dr. Bill Morice

288

NF155: John Mills, Ph.D.

289

How AI is Shaping the Future of Laboratory Medicine: Dr. Bill Morice

290

Mitochondrial disease: Linda Hasadsri, M.D., Ph.D.

291

The Value of a Flu Vaccine Amid COVID-19: Dr. Bill Morice

292

T-cell Lymphoma Testing: Dr. Andrew Feldman

293

COVID-19 National Strategy: Dr. Bill Morice

294

PGXQP: Ann Moyer, M.D., Ph.D.

295

COVID-19 Vaccine Myths: Dr. Bill Morice & Dr. Matt Binnicker

296

COVID-19 Vaccine Boosters: Dr. Bill Morice

297

Candida Auris: Dr. Nancy Wengenack

298

COVID-19 Breakthrough Infections: Dr. Bill Morice

299

COVID-19 Update: Dr. Bill Morice

300

MAG Antibody Testing: John Mills, Ph.D.

301

COVID-19 Surge: Dr. Bill Morice

302

Coronavirus Delta Variant: Dr. Bill Morice

303

Vector-Borne Diseases: Dr. Bobbi Pritt & Dr. Bill Morice

304

Disaccharidase Activity Panel: Puanani (Pua) E. Hopson, D.O.

305

Lab fee reimbursement: Dr. Bill Morice

306

Kelch-11: Divyanshu (Div) Dubey, M.B.B.S.

307

The Current State of COVID-19: Dr. Bill Morice

308

NELL-1: Sanjeev Sethi, M.D., Ph.D.

309

Leading in Laboratory Medicine: Dr. Bill Morice

310

West Nile virus PCR testing: Bobbi Pritt, M.D.

311

MayoComplete Solid Tumor Panel: Kevin C. Halling, M.D., Ph.D.

312

Mayo Clinic, Thermo Fisher Collaboration: Dr. Bill Morice

313

Laboratory Medicine After COVID-19: Dr. Bill Morice

314

TMA: Meera Sridharan, M.D., Ph.D.

315

Mayo Clinic Laboratories: Dr. Bill Morice

316

Lab Innovation During COVID-19: Dr. Bill Morice

317

Autoimmune Profile Updates: Andrew McKeon, M.B., B.Ch., M.D.

318

COVID-19 Vaccine Safety: Dr. Bill Morice

319

COVID-19 Testing Update: Joseph Yao, M.D.

320

Vaccine Passports: Dr. Bill Morice

321

Myasthenia Gravis: Christopher Klein, M.D.

322

COVID-19 Vaccine Update: Dr. Bill Morice

323

COVID-19 Vaccine Hesitancy: Dr. Bill Morice

324

The Path to Leadership: Dr. Bill Morice

325

Female Leadership at Mayo Clinic: Dr. Bill Morice

326

The Future of Lab Medicine Beyond COVID-19: Dr. Bill Morice

327

How COVID-19 Changed the Future of Lab Medicine: Dr. Bill Morice

328

Paraneoplastic Vision Loss Evaluation: Andrew McKeon, M,B., B.Ch., M.D.

329

The Impact of COVID-19 Variants: Dr. Matthew Binnicker

330

MASS-FIX: David Murray, M.D., Ph.D.

331

National COVID-19 Strategy: Dr. Bill Morice

332

Debunking COVID-19 Vaccine Myths: Dr. Bill Morice

333

Pancreatic Elastase Test: Puanani Hopson, D.O.

334

Laboratory Medicine in 2021 and Beyond: Dr. Bill Morice

335

COVID-19 Variants: Dr. Bill Morice

336

2020 COVID-19 Recap: Dr. Bill Morice

337

Dendritic Cell Enumeration Test: Amir Sadighi Akha, M.D., D.Phil.

338

Soaring Interest in Health Care Professions: Dr. Bill Morice

339

Updated Testing Algorithms for Plasma Cell Proliferative Disorders: Xinjie Xu, Ph.D.

340

Debunking Mask Myths: Dr. Bill Morice

341

Paraffin-Embedded Tissue Testing for COVID-19: Anja Roden, M.D.

342

Masks and COVID-19 Prevention: Dr. Bill Morice

343

Hereditary Hearing Loss: Nicole Boczek, Ph.D.

344

COVID-19 Vaccine Update: Dr. Bill Morice

345

COVID-19 Antibody Testing Update: Elitza Theel, Ph.D.

346

Treatment for COVID-19: Dr. Bill Morice

347

Alpha-Gal Testing: Joshua Bornhorst, Ph.D.

348

COVID-19 and Herd Immunity: Dr. Bill Morice

349

Distinguishing COVID-19 From Other Respiratory Illnesses: Aaron Tande, M.D.

350

COVID-19 Testing 101: Dr. Bill Morice

351

B-Cell Lymphoblastic Leukemia Monitoring for Minimal Residual Disease: Min Shi, M.D., Ph.D.

352

Enjoying Fall Activities Safely During COVID-19: Dr. Bill Morice

353

Coagulopathies and COVID-19: Nahla Heikal, M.D.

354

Staying Safe Amid a Surge in COVID-19: Dr. Bill Morice

355

MDM2 Gene Amplification: William Sukov, M.D.

356

Behind the Scenes in a Processing Lab During COVID-19: Jonathan Berry

357

COVID-19 – At-Home Sample Collection vs. At-Home Testing: Dr. Bill Morice

358

COVID Testing at Home: Dr. Bill Morice

359

Different Forms of Masking: Dr. Bill Morice

360

Quality Management during COVID-19: Jill Hill

361

Screening and Surveillance Testing: Dr. Bill Morice

362

Labor Day Weekend Precautions: Dr. Bill Morice

363

Laboratory Perspective of COVID-19: Aimee Boerger and Emily Fernholz

364

Leadership in a Time of Uncertainty: Dr. Bill Morice

365

Maximizing Testing Capacity: Dr. Bill Morice

366

Herd Immunity: Dr. Bill Morice

367

600th Case of the Week on Creepy Dreadful Wonderful Parasites: Dr. Bobbi Pritt

368

Pooling and Precautions: Dr. Bill Morice

369

Benefits of Wearing a Mask: Dr. Bill Morice

370

Supply Chain Management during COVID-19: Dr. Paul Jannetto

371

Delta Air Lines Partnership: Dr. Bill Morice

372

Neutralizing Antibody Assay, Explained: Dr. John Mills

373

Future of COVID-19 Laboratory Testing: Dr. Bill Morice

374

New COVID-19 Test Launch and Employee Testing: Dr. Bill Morice

375

Serology Testing for COVID-19: Dr. Elitza Theel

376

Innovation in COVID-19 Testing: Dr. Bill Morice

377

Using COVID-19 Testing to Help Restart the Economy: Dr. Bill Morice

378

Microbiology Leadership during the COVID-19 Pandemic: Dr. Robin Patel

379

Evolution of the COVID-19 Pandemic: Dr. Bill Morice

380

Podcasting Discussion with the Bow Tie Bandit of Blood: Dr. Justin Kreuter

381

State-Level Testing for COVID-19: Dr. Bill Morice

382

Increased PCR Testing Capacity for COVID-19: Dr. Joseph Yao

383

Leadership and Collaboration During COVID-19: Dr. Bill Morice

384

Drive-up Phlebotomy Services for Serology Testing: Nicole Kang

385

Minnesota Partnership for COVID-19 Pandemic: Dr. Bill Morice

386

Understanding COVID-19 Testing Options: Dr. Matt Binnicker

387

Leadership during the COVID-19 Pandemic: Dr. Bill Morice

388

Serology Testing for COVID-19: Dr. Elitza Theel

389

Coming Soon: Answers from the Lab Podcast